Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
26 results
D1.372 - Potential blood biomarkers of disease activity in patients with chronic spontaneous urticaria
D1.375 - Ciclosporin for omalizumab-refractory CSU in a Paediatric population in Cork University Hospital: a case series
D1.376 - Emerging inmunomodulatory agents for atopic dermatitis
D1.377 - Berotralstat effectively controls a type 2 Hereditary Angioedema patient, refractory to other long-term prophylaxis treatments – Case report
D1.378 - Evaluating the efficacy of dupilumab treatment for atopic dermatitis across geographic areas: A systematic review and meta-regression analysis
D1.379 - AllergoOncology: Generation of Equinized Anti-PD-L1 mAbs with Specific Equine Constant Regions by MOE-PCR Ligation-Independent Cloning (LIC)
D1.380 - Quicker EASI 75 or greater decline of DLQI - is it significant? Comparison of dupilumab treatment among children and adults in two centres in Cracow
D1.383 - Nonimmediate hypersensitivity reaction to Lanadelumab in a patient with Hereditary Angioedema: a case report
D1.384 - Long-term Prophylaxis with Lanadelumab in Hereditary and Acquired Angioedema: A Single-Center Retrospective-Prospective “Real-Life” Analysis
D1.385 - Dupilumab Treatment Effects on Atopic Manifestations in Patients with Inborn Errors of Immunity
D1.386 - Impact of dupilumab on allergen specific immunoglobulin E production
D2.262 - Measurement of tryptasemia in a university hospital: prescribing reality versus recommendations
D2.263 - Anaphylaxis induced by goat’s and sheep’s milk: an allergen that we should keep under surveillance
D2.264 - Food-induced Anaphylaxis: Characterization and Trends of a Four-year Single-center Survey
D2.265 - Allergy to peas and lentils: data from the Allergy-Vigilance Network
D2.266 - Four-Year Analysis of the Incidence and Clinical Features of Perioperative Hypersensitivity Reactions in the Allergy-Anaesthesia Unit, Universitary Hospital Cruz Roja
D2.267 - MiRNA-29a is downregulated in food anaphylaxis and involved in the endothelial glycocalyx stability
D2.269 - Diagnostic challenges in evaluating diagnosis of mast cell disorder in a patient with severe allergy to hymenoptera venom
D2.270 - Roadmap of anaphylaxis registries across the world
D2.271 - The non-mandatory food allergens that we should not sweep under the rug: data from the Allergy-Vigilance Network
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download